US Bancorp’s Sagimet Biosciences SGMT Stock Holding History
Bought
Maintained
Sold
Other funds holding SGMT
SVCM
US Bancorp's SGMT Position: Q3 2026 in Review
US Bancorp opened a new position in Sagimet Biosciences (SGMT) in Q3 2026: 1,350 shares worth $13.3K. The stake represents ﹤0.01% of the portfolio and ranks #3388 among its holdings. This is a return to the name: US Bancorp previously reported a position in SGMT as recently as Q3 2025.
US Bancorp first reported a position in SGMT in Q3 2025 and has held it in 2 quarters since. 117 funds tracked by Wall St. Rank hold SGMT as of Q3 2026.
- US Bancorp held 1,350 shares of Sagimet Biosciences worth $13.3K as of Q3 2026.
- Sagimet Biosciences was a new US Bancorp position in Q3 2026.
- Sagimet Biosciences made up ﹤0.01% of US Bancorp's portfolio in Q3 2026, its #3388 holding.
- US Bancorp first reported a position in Sagimet Biosciences in Q3 2025 and has held it in 2 quarters since.
- 117 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q3 2026.
Based on US Bancorp's 13F filing for Q3 2026, filed 5 Nov 2026.